sh-vector-shutterstock-com-1
SH-Vector / Shutterstock.com
10 September 2015PharmaClaire Phipps-Jones

London calling: the benefits of the UPC’s new home

The announcement on August 11 of the location of the London central division of the Unified Patent Court (UPC) should be welcomed by the life sciences sector. Not only is the new court at Aldgate Tower in the middle of legal London and a stone’s throw from MedCity (the organisation managing a life sciences cluster including London, Cambridge and Oxford), it’s also easily accessible to the hotbed of innovators and manufacturers based in London and the south-east and to international court users alike.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
14 August 2026   Pressure for generic manufacturers of the blockbuster heart drug Entresto is mounting as the Swiss pharma company secures a win over a challenge to its UK patent protection.
Pharma
11 August 2026   A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.
Pharma
10 August 2026   Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law.